Mechanisms of Yajieshaba in the treatment of liver fibrosis through the Keap1-Nrf2 signaling pathway.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1124015
- By:
- Publication type:
- Article
Works by Yuanmei BAI
Results: 7
1
2
Risk Factors for Acute Kidney Injury in Patients Receiving Antibiotic Therapy; A Systematic Review and Meta -- Analysis.
- Published in:
- Medicinal Plant, 2024, v. 15, n. 4, p. 59, doi. 10.19600/j.cnki.issn2152-3924.2024.04.013
- By:
- Publication type:
- Article
3
Advances in Studies on Treatment of Hepatic Fibrosis with Dai and Western Medicine.
- Published in:
- Medicinal Plant, 2022, v. 13, n. 4, p. 81, doi. 10.19600/j.cnki.issn2152-3924.2022.04.019
- By:
- Publication type:
- Article
4
Research Progress in the Treatment of Gouty Nephropathy with Dai and Western Medicine.
- Published in:
- Medicinal Plant, 2022, v. 13, n. 4, p. 99, doi. 10.19600/j.cnki.issn2152-3924.2022.04.022
- By:
- Publication type:
- Article
5
DaiTongXiao improves gout nephropathy by inhibiting inflammatory response through the TLR4/MyD88/NF-κB pathway.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1447241
- By:
- Publication type:
- Article
6
Ameliorative action of "daitongxiao" against hyperuricemia includes the "uric acid transporter group".
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1300131
- By:
- Publication type:
- Article
7
Mechanism of flavonoids in the treatment of gouty arthritis (Review).
- Published in:
- Molecular Medicine Reports, 2024, v. 30, n. 2, p. N.PAG, doi. 10.3892/mmr.2024.13256
- By:
- Publication type:
- Article